BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 17977941)

  • 1. Src tyrosine kinase alters gating of hyperpolarization-activated HCN4 pacemaker channel through Tyr531.
    Li CH; Zhang Q; Teng B; Mustafa SJ; Huang JY; Yu HG
    Am J Physiol Cell Physiol; 2008 Jan; 294(1):C355-62. PubMed ID: 17977941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PP2 prevents β-adrenergic stimulation of cardiac pacemaker activity.
    Huang J; Lin YC; Hileman S; Martin KH; Hull R; Yu HG
    J Cardiovasc Pharmacol; 2014 Jun; 63(6):533-43. PubMed ID: 24566462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mechanism of modulation of hyperpolarization-activated cyclic nucleotide-gated channels by Src kinase.
    Zong X; Eckert C; Yuan H; Wahl-Schott C; Abicht H; Fang L; Li R; Mistrik P; Gerstner A; Much B; Baumann L; Michalakis S; Zeng R; Chen Z; Biel M
    J Biol Chem; 2005 Oct; 280(40):34224-32. PubMed ID: 16079136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutively active Src tyrosine kinase changes gating of HCN4 channels through direct binding to the channel proteins.
    Arinsburg SS; Cohen IS; Yu HG
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):578-86. PubMed ID: 16680072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation and modulation of hyperpolarization-activated HCN4 channels by protein kinase A in the mouse sinoatrial node.
    Liao Z; Lockhead D; Larson ED; Proenza C
    J Gen Physiol; 2010 Sep; 136(3):247-58. PubMed ID: 20713547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PP2 prevents isoproterenol stimulation of cardiac pacemaker activity.
    Huang J; Lin YC; Hileman S; Martin KH; Hull R; Yu HG
    J Cardiovasc Pharmacol; 2015 Feb; 65(2):193-202. PubMed ID: 25658311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associated changes in HCN2 and HCN4 transcripts and I(f) pacemaker current in myocytes.
    Zhang Q; Huang A; Lin YC; Yu HG
    Biochim Biophys Acta; 2009 May; 1788(5):1138-47. PubMed ID: 19236845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenergic regulation of HCN4 channel requires protein association with β2-adrenergic receptor.
    Greene D; Kang S; Kosenko A; Hoshi N
    J Biol Chem; 2012 Jul; 287(28):23690-7. PubMed ID: 22613709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias.
    Michels G; Er F; Khan I; Südkamp M; Herzig S; Hoppe UC
    Circulation; 2005 Feb; 111(4):399-404. PubMed ID: 15687126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rescue of a trafficking defective human pacemaker channel via a novel mechanism: roles of Src, Fyn, and Yes tyrosine kinases.
    Lin YC; Huang J; Kan H; Frisbee JC; Yu HG
    J Biol Chem; 2009 Oct; 284(44):30433-40. PubMed ID: 19748888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular context and multiple channel domains determine cAMP sensitivity of HCN4 channels: ligand-independent relief of autoinhibition in HCN4.
    Liao Z; Lockhead D; St Clair JR; Larson ED; Wilson CE; Proenza C
    J Gen Physiol; 2012 Nov; 140(5):557-66. PubMed ID: 23109717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibition differentially regulates heterologously expressed HCN channels.
    Yu HG; Lu Z; Pan Z; Cohen IS
    Pflugers Arch; 2004 Jan; 447(4):392-400. PubMed ID: 14634823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the cAMP-dependent gating in the human HCN4 channel.
    Xu X; Vysotskaya ZV; Liu Q; Zhou L
    J Biol Chem; 2010 Nov; 285(47):37082-91. PubMed ID: 20829353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic processing of HCN2 and co-assembly with HCN4 in the generation of cardiac pacemaker channels.
    Ye B; Nerbonne JM
    J Biol Chem; 2009 Sep; 284(38):25553-9. PubMed ID: 19574228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.
    Stieber J; Herrmann S; Feil S; Löster J; Feil R; Biel M; Hofmann F; Ludwig A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15235-40. PubMed ID: 14657344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode shifts in the voltage gating of the mouse and human HCN2 and HCN4 channels.
    Elinder F; Männikkö R; Pandey S; Larsson HP
    J Physiol; 2006 Sep; 575(Pt 2):417-31. PubMed ID: 16777944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.
    Ye B; Balijepalli RC; Foell JD; Kroboth S; Ye Q; Luo YH; Shi NQ
    Biochemistry; 2008 Nov; 47(47):12312-8. PubMed ID: 19238754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase.
    Ahern CA; Zhang JF; Wookalis MJ; Horn R
    Circ Res; 2005 May; 96(9):991-8. PubMed ID: 15831816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking.
    Erlenhardt N; Kletke O; Wohlfarth F; Komadowski MA; Clasen L; Makimoto H; Rinné S; Kelm M; Jungen C; Decher N; Meyer C; Klöcker N
    Pflugers Arch; 2020 Dec; 472(12):1733-1742. PubMed ID: 33095298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel HCN4 Blockers with Unique Blocking Kinetics and Binding Properties.
    Nakashima K; Nakao K; Matsui H
    SLAS Discov; 2021 Aug; 26(7):896-908. PubMed ID: 34041946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.